Assessing cancer clinical trials: will your patient benefit from a 'breakthrough'?
Cancer patients and their families often ask their primary care physicians if a new treatment reported in the news can help them. Physicians familiar with the long and complicated process of oncologic clinical trials are in the best position to assess the potential for clinical benefit from a new antineoplastic therapy.
Markman
Maurie
M
Taussing Cancer Center and Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, OH 44195, USA. markmam@ccf.org
D002986:Clinical Trials as Topic; D003657:Decision Making; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D018579:Patient Selection; D010821:Physicians, Family